INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE);INSTITUT CURIE;UNIVERSITE DAXI-MARSEILLE;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE;UNIVERSITE D'AXI-MARSEILLE
The invention relates to the use of cystamine, cysteamine, or a salt thereof, or of calcineurin inhibitors for treating a MeCP2-associated disorder such as Rett syndrome.